A long Covid col­lab­o­ra­tive kicks off with $15M to study caus­es of lin­ger­ing dis­ease, con­duct clin­i­cal tri­als

The Covid-19 pan­dem­ic has left mil­lions of peo­ple with lin­ger­ing symp­toms months af­ter ini­tial di­ag­no­sis, and none of the hand­ful of bio­phar­mas that have at­tempt­ed to treat the so-called long Covid have suc­ceed­ed yet.

A new col­lab­o­ra­tion — bring­ing to­geth­er re­searchers from lead­ing in­sti­tutes in acad­e­mia — will hone in on what the virus does to “dri­ve chron­ic dis­ease,” re­search how SARS-CoV-2 af­fects the im­mune sys­tem and what ef­fects it could have on cog­ni­tive func­tion, nerve sig­nal­ing and oth­er process­es. The group al­so wants to dig in­to the root cause of the dis­ease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER